The Uptake Inhibitors Cocaine and Benztropine Differentially Alter the Conformation of the Human Dopamine Transporter

This publication has 26 references indexed in Scilit:

• Binding domains for blockers and substrates on the dopamine transporter in rat striatal membranes studied by protection against N-ethylmaleimide-induced reduction of [3H]WIN 35,428 binding
  Naunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1996
• Binding domains for blockers and substrates on the cloned human dopamine transporter studied by protection against N-Ethylmaleimide-induced reduction of 2β-carbomethoxy-3β-(4-fluorophenyl)[3H]tropane ([3H]WIN 35,428) binding
  Biochemical Pharmacology, 1996
• Cocaine and GBR 12783 recognize nonidentical, overlapping binding domains on the dopamine neuronal carrier
  European Journal of Pharmacology: Molecular Pharmacology, 1994
• Cocaine and dopamine differentially protect [3H]mazindol binding sites from alkylation by N-ethylmaleimide
  European Journal of Pharmacology: Molecular Pharmacology, 1992
• The dopamine hypothesis of the reinforcing properties of cocaine
  Trends in Neurosciences, 1991
• N-ethylmaleimide irreversibly inhibits the binding of [3H]threo-(±)-methylphenidate to the stimulant recognition site
  Neuropharmacology, 1990
• Cocaine Receptors on Dopamine Transporters Are Related to Self-Administration of Cocaine
  Science, 1987
• High Affinity Stereospecific Binding of [³H] Cocaine in Striatum and its Relationship to the Dopamine Transporter
  Membrane Biochemistry, 1987
• Structural requirements for cocaine congeners to interact with dopamine and serotonin uptake sites in mouse brain and to induce stereotyped behavior
  Biochemical Pharmacology, 1986
• Role of Transmitter Uptake Mechanisms in Synaptic Neurotransmission
  British Journal of Pharmacology, 1971